Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 46.91%299.12M | ---- | 2,777.96%203.61M | ---- | -100.94%-7.6M | ---- | 71.09%812.84M | ---- | 5.79%475.08M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 51.26%-10.22M | ---- | -16.50%-20.97M | ---- | -41.49%-18M | ---- | -103.91%-12.72M | ---- | -36.67%-6.24M |
| Attributable subsidiary (profit) loss | ---- | 7.73%4.47M | ---- | 427.57%4.15M | ---- | -78.48%787K | ---- | --3.66M | ---- | ---- |
| Impairment and provisions: | ---- | -84.29%4.91M | ---- | -49.45%31.24M | ---- | 48.51%61.8M | ---- | 90.80%41.62M | ---- | -20.97%21.81M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | -37.27%11.81M | ---- | -15.48%18.82M | ---- | 473.06%22.27M | ---- | -77.75%3.89M |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | -97.36%785K | ---- | 716.39%29.68M | ---- | 27.76%3.64M | ---- | -58.63%2.85M |
| -Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -43.59%2.87M | ---- | 110.22%5.08M |
| -Other impairments and provisions | ---- | -73.69%4.91M | ---- | 40.26%18.65M | ---- | 3.52%13.3M | ---- | 28.45%12.85M | ---- | 1,100.48%10M |
| Revaluation surplus: | ---- | 336.20%907K | ---- | -131.55%-384K | ---- | 42.67%1.22M | ---- | 1,883.72%853K | ---- | 101.03%43K |
| -Other fair value changes | ---- | 336.20%907K | ---- | -131.55%-384K | ---- | 42.67%1.22M | ---- | 1,883.72%853K | ---- | 101.03%43K |
| Asset sale loss (gain): | ---- | 1,900.50%3.98M | ---- | -85.81%199K | ---- | 104.08%1.4M | ---- | -1,150.63%-34.32M | ---- | 512.50%3.27M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -13,780.31%-35.95M | ---- | ---259K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 1,900.50%3.98M | ---- | -85.81%199K | ---- | -13.78%1.4M | ---- | -53.89%1.63M | ---- | 684.74%3.53M |
| Depreciation and amortization: | ---- | -14.80%139.7M | ---- | 1.77%163.96M | ---- | -21.25%161.11M | ---- | -10.46%204.58M | ---- | 14.82%228.47M |
| -Amortization of intangible assets | ---- | -4.33%19.93M | ---- | -12.22%20.83M | ---- | -1.89%23.73M | ---- | -16.99%24.19M | ---- | -8.29%29.14M |
| Financial expense | ---- | -3.99%67.52M | ---- | 2.69%70.33M | ---- | -12.67%68.49M | ---- | -8.93%78.42M | ---- | -28.34%86.11M |
| Exchange Loss (gain) | ---- | -97.04%54K | ---- | 156.45%1.83M | ---- | -346.98%-3.23M | ---- | -20.13%1.31M | ---- | -39.00%1.64M |
| Special items | ---- | 68.80%4.57M | ---- | 131.39%2.71M | ---- | 48.35%1.17M | ---- | 28.34%788K | ---- | -97.96%614K |
| Operating profit before the change of operating capital | ---- | 12.78%515.01M | ---- | 70.95%456.66M | ---- | -75.65%267.14M | ---- | 35.30%1.1B | ---- | -1.02%810.79M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -117.89%-28.96M | ---- | 181.62%161.89M | ---- | -313.33%-198.36M | ---- | 631.61%92.98M | ---- | -155.66%-17.49M |
| Accounts receivable (increase)decrease | ---- | -960.44%-64.35M | ---- | 109.16%7.48M | ---- | -252.56%-81.61M | ---- | 28.98%53.49M | ---- | -41.15%41.47M |
| Accounts payable increase (decrease) | ---- | -182.99%-78.32M | ---- | -21.49%94.37M | ---- | -47.04%120.2M | ---- | -12.49%226.97M | ---- | 329.21%259.35M |
| Special items for working capital changes | ---- | 99.45%-1.93M | ---- | -202.61%-352.74M | ---- | 203.36%343.78M | ---- | -408.37%-332.59M | ---- | -486.18%-65.42M |
| Cash from business operations | ---- | -7.13%341.45M | ---- | -18.51%367.66M | ---- | -60.35%451.15M | ---- | 10.61%1.14B | ---- | 35.63%1.03B |
| Other taxs | ---- | -234.30%-162.78M | ---- | 45.95%-48.69M | ---- | 32.92%-90.09M | ---- | -50.67%-134.29M | ---- | 4.18%-89.13M |
| Special items of business | -227.82%-126.05M | ---- | -32.46%98.61M | ---- | 50.82%145.99M | ---- | -85.33%96.8M | ---- | 46.05%659.91M | ---- |
| Net cash from operations | -227.82%-126.05M | -43.98%178.67M | -32.46%98.61M | -11.66%318.97M | 50.82%145.99M | -64.02%361.06M | -85.33%96.8M | 6.81%1B | 46.05%659.91M | 41.20%939.57M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -27.29%3.15M | -59.84%8.42M | -56.17%4.33M | 16.50%20.97M | -9.07%9.88M | 41.49%18M | 63.80%10.87M | 103.91%12.72M | 90.22%6.64M | 36.67%6.24M |
| Restricted cash (increase) decrease | -1,100.00%-290K | ---- | 107.82%29K | ---- | -274.75%-371K | ---- | 75.19%-99K | ---- | -211.72%-399K | ---- |
| Loan receivable (increase) decrease | --0 | --45.06M | --36.6M | --0 | ---- | 134.41%20M | 738.98%20M | -1,266.82%-58.13M | ---3.13M | 82.15%-4.25M |
| Decrease in deposits (increase) | -563.24%-269.08M | 53.18%118.68M | 118.04%58.09M | -50.19%77.48M | -271.87%-322.02M | 159.90%155.55M | 227.17%187.36M | 39.90%-259.67M | 51.13%-147.33M | -4,878.96%-432.07M |
| Sale of fixed assets | 13.71%1.73M | 1,758.16%2.62M | 30,240.00%1.52M | -66.35%141K | -98.10%5K | -91.09%419K | -64.17%263K | 16.24%4.7M | -76.11%734K | -83.00%4.05M |
| Purchase of fixed assets | 63.17%-13.3M | -46.25%-61.75M | -79.72%-36.1M | 51.71%-42.22M | 52.86%-20.09M | 9.80%-87.42M | 3.73%-42.61M | -57.18%-96.93M | -82.01%-44.26M | 76.36%-61.67M |
| Purchase of intangible assets | -101.10%-78.26M | 16.25%-76.54M | 7.47%-38.92M | -34.95%-91.39M | 5.10%-42.06M | 45.88%-67.72M | 33.26%-44.32M | -107.58%-125.13M | -142.49%-66.4M | -32.18%-60.28M |
| Acquisition of subsidiaries | ---- | -43.56%-106.17M | 58.27%-13.85M | -14.12%-73.95M | 36.15%-33.2M | -4,246.08%-64.8M | ---52M | 97.34%-1.49M | ---- | 33.44%-56.1M |
| Recovery of cash from investments | ---- | 345.20%4.45M | 45.20%1.45M | --1M | --1M | ---- | ---- | -6.19%1M | ---- | -99.80%1.07M |
| Cash on investment | ---- | 57.14%-3M | 92.09%-3M | 60.45%-7M | -110.20%-37.92M | 44.69%-17.7M | 39.87%-18.04M | ---32M | ---30M | ---- |
| Other items in the investment business | --13.47M | ---- | ---- | ---- | ---- | ---- | ---- | -38.62%64.97M | ---- | 3,569.12%105.84M |
| Net cash from investment operations | -3,476.50%-342.58M | 40.67%-68.22M | 102.28%10.15M | -163.23%-114.97M | -824.01%-444.76M | 91.09%-43.68M | 121.62%61.43M | 1.45%-489.96M | 0.34%-284.15M | -793.18%-497.18M |
| Net cash before financing | -530.90%-468.63M | -45.85%110.45M | 136.40%108.75M | -35.73%203.99M | -288.82%-298.77M | -38.21%317.38M | -57.89%158.23M | 16.10%513.62M | 125.38%375.76M | -39.99%442.39M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 21.93%1.06B | 43.76%1.37B | 71.32%866.39M | 4.67%951.93M | 4.18%505.73M | 31.85%909.5M | 42.68%485.43M | -32.45%689.79M | -55.81%340.22M | 76.02%1.02B |
| Refund | -6.14%-942.88M | -39.81%-1.15B | -122.16%-888.3M | 7.78%-825.33M | 18.77%-399.84M | -11.32%-894.94M | 1.43%-492.26M | 21.16%-803.96M | 17.63%-499.42M | 32.29%-1.02B |
| Interest paid - financing | -4.98%-36.78M | 4.34%-65.43M | -1.80%-35.04M | -2.74%-68.4M | 14.99%-34.42M | 14.34%-66.57M | 15.19%-40.48M | 7.00%-77.72M | -1.06%-47.73M | 25.00%-83.57M |
| Dividends paid - financing | -8.14%-37.56M | -80.51%-69.7M | ---34.73M | 83.77%-38.61M | ---- | -10.49%-237.93M | -49.58%-191.43M | -11.09%-215.34M | 3.36%-127.98M | -502.75%-193.84M |
| Absorb investment income | --3M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --600K |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 50.29%-9.57M | ---- | -64.49%-19.24M |
| Other items of the financing business | 791.67%518.88M | -18.61%-98.17M | -79.06%58.19M | 52.06%-82.77M | 17,963.37%277.95M | ---172.64M | 91.08%-1.56M | ---- | -39.16%-17.45M | ---- |
| Net cash from financing operations | 1,687.13%559.29M | 67.22%-22.01M | -110.16%-35.24M | 85.58%-67.16M | 243.35%346.75M | -10.55%-465.89M | 31.86%-241.89M | -39.89%-421.44M | -993.64%-354.97M | 72.13%-301.26M |
| Effect of rate | -209.19%-737K | 226.60%1.25M | -60.15%675K | -128.74%-985K | -10.42%1.69M | -43.53%3.43M | -30.71%1.89M | 208.38%6.07M | 345.19%2.73M | 162.75%1.97M |
| Net Cash | 23.33%90.67M | -35.37%88.44M | 53.20%73.52M | 192.14%136.83M | 157.36%47.99M | -261.11%-148.51M | -502.41%-83.66M | -34.69%92.18M | -84.52%20.79M | 141.04%141.13M |
| Begining period cash | 32.51%358.13M | 101.07%270.26M | 101.07%270.26M | -51.91%134.41M | -51.91%134.41M | 54.21%279.49M | 54.21%279.49M | 375.13%181.24M | 375.13%181.24M | -89.99%38.15M |
| Items Period | 22,812.50%1.82M | ---1.82M | ---8K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash at the end | 30.61%449.87M | 32.51%358.13M | 87.10%344.44M | 101.07%270.26M | -6.90%184.09M | -51.91%134.41M | -3.44%197.72M | 54.21%279.49M | 18.34%204.76M | 375.13%181.24M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.